Literature DB >> 10196192

Complete mapping of divergent amino acids responsible for differential ligand binding of folate receptors alpha and beta.

K M Maziarz1, H L Monaco, F Shen, M Ratnam.   

Abstract

The folate receptor (FR) type alpha may be distinguished from FR-beta by its higher affinity for the circulating folate coenzyme, (6S)-5-methyltetrahydrofolate (5-CH3H4folate), and its opposite stereospecificity for reduced folate coenzymes. Previous studies showed that a single leucine to alanine substitution at position 49 of the mature protein sequence is responsible for the functional divergence of FR-beta (Shen, F., Zheng, X., Wang, H., and Ratnam, M. (1997) Biochemistry 36, 6157-6163); however, the results also indicated that the minimum requirement for conversion of FR-beta to the functional equivalent of FR-alpha should include amino acid substitution(s) downstream of residue 92 in addition to mutation of L49A. To pinpoint those residues, chimeric FR-betaL49A/FR-alpha constructs including progressively shorter segments of FR-alpha downstream of position 92 as well as selected point mutants were studied. Simultaneous substitution of Leu-49, Phe-104, and Gly-166 in FR-beta with the corresponding FR-alpha residues Ala, Val, and Glu, respectively, reconstituted the ligand binding characteristics of FR-alpha. The results also exclude a role for other residues in FR-alpha in determining its functional divergence. A homology model of FR-alpha based on the three-dimensional structure of the chicken riboflavin-binding protein is used to show the position of residues 49, 104, and 166 in relation to the hydrophobic cleft corresponding to the riboflavin-binding pocket.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196192     DOI: 10.1074/jbc.274.16.11086

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  IgA Fc-folate conjugate activates and recruits neutrophils to directly target triple-negative breast cancer cells.

Authors:  Eric D Frontera; Rafa M Khansa; Dana L Schalk; Lauren E Leakan; Tracey J Guerin-Edbauer; Manohar Ratnam; David H Gorski; Cecilia L Speyer
Journal:  Breast Cancer Res Treat       Date:  2018-08-28       Impact factor: 4.872

2.  Intermediate states in the binding process of folic acid to folate receptor α: insights by molecular dynamics and metadynamics.

Authors:  Stefano Della-Longa; Alessandro Arcovito
Journal:  J Comput Aided Mol Des       Date:  2014-10-17       Impact factor: 3.686

Review 3.  Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues.

Authors:  Rongbao Zhao; Larry H Matherly; I David Goldman
Journal:  Expert Rev Mol Med       Date:  2009-01-28       Impact factor: 5.600

4.  Folate receptor-mediated targeted polymeric gadolinium complexes for magnetic resonance imaging in pulmonary tumor xenografts.

Authors:  Zheng Yuan; Wen-Tao Li; Xiao-Dan Ye; Shi-Yuan Liu; Xiang-Sheng Xiao
Journal:  Exp Ther Med       Date:  2012-03-05       Impact factor: 2.447

5.  Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition.

Authors:  Ardian S Wibowo; Mirage Singh; Kristen M Reeder; Joshua J Carter; Alexander R Kovach; Wuyi Meng; Manohar Ratnam; Faming Zhang; Charles E Dann
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-09       Impact factor: 11.205

6.  Identification of a PET Radiotracer for Imaging of the Folate Receptor-α: A Potential Tool to Select Patients for Targeted Tumor Therapy.

Authors:  Patrycja Guzik; Hsin-Yu Fang; Luisa M Deberle; Martina Benešová; Susan Cohrs; Silvan D Boss; Simon M Ametamey; Roger Schibli; Cristina Müller
Journal:  J Nucl Med       Date:  2021-01-15       Impact factor: 10.057

7.  Characterization of the human folate receptor alpha via novel antibody-based probes.

Authors:  Daniel J O'Shannessy; Elizabeth B Somers; Earl Albone; Xin Cheng; Young Chul Park; Brian E Tomkowicz; Yoshitomo Hamuro; Thomas O Kohl; Tracy M Forsyth; Robert Smale; Yao-Shi Fu; Nicholas C Nicolaides
Journal:  Oncotarget       Date:  2011-12

8.  Insilco analysis of functionally important residues in folate receptors.

Authors:  Kalidoss Ramamoorthy; Sirisha Potala; Rama Shanker Verma
Journal:  Bioinformation       Date:  2007-12-28

9.  Accelerated killing of cancer cells using a multifunctional single-walled carbon nanotube-based system for targeted drug delivery in combination with photothermal therapy.

Authors:  Prashanti Jeyamohan; Takashi Hasumura; Yutaka Nagaoka; Yasuhiko Yoshida; Toru Maekawa; D Sakthi Kumar
Journal:  Int J Nanomedicine       Date:  2013-07-24

Review 10.  Targeted treatment of folate receptor-positive platinum-resistant ovarian cancer and companion diagnostics, with specific focus on vintafolide and etarfolatide.

Authors:  Loredana Serpe; Margherita Gallicchio; Roberto Canaparo; Franco Dosio
Journal:  Pharmgenomics Pers Med       Date:  2014-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.